Intrexon Corporation (XON) was a big mover last session with shares rising over 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the past one month’s volatile price range of $24.74 to $28.63.
This biotechnology company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn’t been in trend either. Yesterday’s rally is encouraging though, so make sure to keep a close watch on this firm in the near future.
Intrexon currently holds a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Better-ranked Med-Drug stocks worth considering include Envision Healthcare Holdings, Inc. (EVHC), ICON plc (ICLR) and Quintiles Transnational Holdings Inc. (Q). All the three stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
INTREXON CORP (XON): Free Stock Analysis Report
ENVISION HEALTHCARE HOLDINGS INC (EVHC): Free Stock Analysis Report
ICON PLC ORD (ICLR): Free Stock Analysis Report
QUINTILES TRANSNATIONAL HOLDINGS (Q): Free Stock Analysis Report
Zacks Investment Research
- Personal Investing Ideas & Strategies
- Finance Trading